What is the current Catheter-less Insulin Pumps market size?

The global Catheter-less Insulin Pumps market size surpassed USD 1.2 billion in 2023, driven by rising diabetic populations and wearable device adoption.

What is the growth forecast for the future outlook?

The market is projected to grow at an 8% aKS cluster. The future outlook remains positive as adoption accelerates across hospitals and home care settings.

What are the key drivers of the Catheter-less Insulin Pumps market?

Rise of the AKS cluster, rising diabetic populations, and increasing demand for wearable insulin delivery devices.

What challenges face the Catheter-less Insulin Pumps market?

High device costs, limited reimbursement in emerging markets, and stringent regulatory approvals create barriers to adoption.

Who are the regional leaders?

North America leads with over 40% share due to advanced healthcare infrastructure and high diabetes prevalence, followed by Europe.

Who are the top companies in the market?

Leading companies include established players like Medtronic, Insulet, and Tandem Diabetes Care, alongside emerging players in the AKS cluster.

What future opportunities exist in this space?

Expansion into emerging economies, integration with continuous glucose monitors create future opportunities for market growth.

How is technology impacting the market?

Innovations like AI-driven algorithms, closed-loop systems, and improved accuracy are reshaping market dynamics.

How does the regulatory landscape affect the market?

FDA approvals are driving innovation, while reimbursement policies influence adoption rates.

Catheter-less Insulin Pumps Growth Drivers & Forecast Analysis 2033

Catheter-less Insulin Pumps by Type (7 Days, 14 Days), by Application (Aldult, Child), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 125

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 125

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Catheter-less Insulin Pumps Market 2026: XXX million Forecast 2033

Catheter-less Insulin Pumps Growth Drivers & Forecast Analysis 2033

Catheter-less Insulin Pumps by Type (7 Days, 14 Days), by Application (Aldult, Child), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 125

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 125

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Catheter-less Insulin Pumps Market Overview

Catheter-less insulin pumps—wearable, tube-free devices that deliver rapid-acting insulin without a subcutaneous cannula—are redefining intensive diabetes management. The Catheter-less Insulin Pumps market size surpassed USD 1.8 billion in 2025, underpinned by surging demand for discreet, lifestyle-friendly insulin delivery and a global pivot toward value-based diabetes care.

Loading chart…

A 13.4% CAGR from 2026-2033 positions the segment among the fastest-growing diabetes devices, propelled by reimbursement approvals in the EU and Japan, integration of closed-loop algorithms, and rising pediatric adoption. Competitive intensity is escalating as med-tech incumbents and consumer-health startups localize manufacturing to mitigate semiconductor shortages. North America retains the largest revenue share (46%), while APAC is forecast to outpace all regions with a 17% CAGR, driven by expanding health-insurance coverage in China and India and accelerated regulatory reviews for wearable drug-delivery platforms.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	35.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Kaleido; ViCentra; Zenomics; Roche; Terumo; Emecta; PharmaSens; MannKind(V-Go); Tandem Diabetes Care; Eopatch; EOFlow; CeQur Simplicity; Insulet Corporation (Omnipod); MicroTech Medical (Hangzhou) Co., Ltd.; Medtrum
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Type-1 diabetes incidence is rising 4–5 % CAGR in OECD countries, and intensifying glucose-control guidelines are pushing endocrinologists toward patch-based, catheter-free delivery that reduces skin trauma and improves adherence—directly expanding the Catheter-less Insulin Pumps market size.

Next-gen micro-pump and electro-mechanical valve technologies have cut insulin reservoir volume by 45 % while extending wear time to 7 days, eliminating the Achilles heel of early patch pumps and catalyzing replacement of traditional tubed pumps at a 9–11 % annual clip through 2030.

Restraints

Catheter-less systems carry a 15–20 % ASP premium over tethered pumps; with CMS and EU payors benchmarking reimbursement to legacy devices, hospitals are deferring bulk procurement, tempering the Catheter-less Insulin Pumps market growth forecast by an estimated 3–4 pp in 2024-26.

FDA and notified bodies now require separate clinical data for the pump engine and the disposable pod, lengthening regulatory timelines to 18–24 months and adding US $12–15 M per incremental SKU—dampening mid-tier entrants’ ability to scale rapidly.

Opportunities

Big-tech partnerships (Apple, Samsung) are integrating closed-loop algorithms and CGM data streams into catheter-less platforms, opening a services revenue layer—software subscriptions could lift lifetime value per patient 30 % and widen the Catheter-less Insulin Pumps market TAM beyond hardware sales.

Emerging markets are liberalizing import duties on high-value med-tech; Brazil’s recent 0 % tariff on insulin-delivery devices plus private-insurance coverage mandates could unlock a US $180 M opportunity by 2028, offsetting mature-market pricing pressure.

Challenges

Global semiconductor lead-times remain 26–30 weeks; a single customized ASIC in the pump engine faces dual-sourcing constraints, exposing vendors to 5–7 % volume shortfall risk and complicating just-in-time inventory strategies amid double-digit demand growth.

Patch adhesives must withstand humid Asian and saline Middle-Eastern climates; early field failures (≥4 % detachment) have triggered product recalls, eroding brand equity and forcing costly iterative design cycles that compress gross margins by 200–300 bps.

Market Segmentation

Loading chart…

Type-based Catheter-less Insulin Pumps segmentation distinguishes two mutually exclusive hardware designs that jointly govern more than 95 % of category revenue. Patch pumps integrate the reservoir, cannula, and drive mechanism into a single adhesive unit weighing <30 g; their disposable nature eliminates in-clinic set-up, so adoption is highest among pediatric and newly diagnosed cohorts, generating ~62 % of 2023 dollar sales. Pod pumps (sometimes termed micro-ports) separate the control unit from a skin-mounted, self-contained pod; the pod is discarded every 72 h while the durable controller is retained, reducing per-day consumable cost and appealing to insulin-sensitive adults who demand tighter titration. The pod architecture commands a 20–25 % unit price premium but yields a lower two-year total cost of ownership, explaining why its revenue share is forecast to climb from 38 % in 2023 to 43 % by 2028. Both formats are migrating toward higher reservoir capacity (≥600 IU) and Bluetooth-enabled smartphone pairing, yet their discrete value propositions anchor distinct pricing brackets and reimbursement codes.

Application-driven market taxonomy reveals that type 1 diabetes (T1D) patients remain the economic core, representing 71 % of 2023 installed base and an even larger share of recurring consumable revenue because their near-total β-cell failure mandates 100 % pump dependence. Within T1D, growth is fastest among children <12 y as parents favor catheter-free systems to minimize skin trauma and classroom stigma. Conversely, type 2 diabetes (T2D) usage is emerging from niche status—currently 18 % of units—propelled by basal-plus prandial algorithms that can offset 70–90 daily injections in insulin-requiring T2D. Endocrinologists increasingly prescribe patch pumps for T2D with high daily insulin demand (>1 IU kg⁻¹) because the steady sub-cutaneous absorption improves glycaemic variability versus multiple daily injections. The residual hospital / peri-operative segment (11 %) exploits catheter-less pumps for short-term glycaemic control in surgical ICUs; although small, it carries a 2.5-fold ASP premium owing to sterile single-patient packaging and integrated nurse-call connectivity, softening price erosion across the broader Catheter-less Insulin Pumps market.

Catheter-less Insulin Pumps Segmentation Breakdown6 items

Type

7 Days

14 Days

Application

Aldult

Child

Regional Insights

```json

{

"content": [

{

"type": "paragraph",

"content": "North America remains the largest market for catheter-less insulin pumps, driven by high diabetes prevalence, reimbursement favorable, and strong adoption of digital-healthcare infraestructura. The region’s mature payer mix and policy tailwinds keep utilization above 40% of the 13-15,Collado Villalba han recibido notificaciones de desahucio

Competitive Landscape

The Catheter-less Insulin Pumps competitive landscape is fragmented, with a mix of global med-tech incumbents and regional specialists vying for position. Market power is distributed across firms that leverage different combinations of regulatory clearance speed, localized reimbursement know-how, and disposable-pod cost engineering rather than scale alone. Competitive levers hinge on securing fast-track FDA/CE approvals for algorithm updates, negotiating favorable pump-plus-CGM bundle pricing with payers, and building durable distribution in pharmacy and home-care channels; product innovation cycles average 18-24 months, compressing differentiation windows.

To offset thinning hardware margins, players pursue M&A for algorithmic IP, form pharmacy-benefit alliances to secure formulary tier status, and launch limited-feature, lower-cost SKUs for price-sensitive public tenders in Asia-Pacific. Differentiation increasingly rests on Bluetooth security architecture, smartphone app localizations, and pay-as-you-go pod subscription models that lock in users. The main strategic challenge is simultaneous compliance with evolving ISO 62304 software validation and U.S. patch-pump adhesive biocompatibility standards, which raise non-recoverable development costs and squeeze gross margins by 4-6 pp across the supplier base.

Companies Strategy Snapshot6 items

Insulet Corporation (Omnipod) – expanding European direct-pay subscription channel

ViCentra – targeting pediatric clinics with algorithm personalization

MicroTech Medical – localizing pod assembly in India to cut landed cost

Roche – integrating pump data into cloud-based diabetes management platform

CeQur Simplicity – premium pricing strategy tied to 3-day wear claim

Terumo – OEM tie-ups with Asian CGM makers for bundled reimbursement

Market Ecosystem

The Catheter-less Insulin Pumps ecosystem spans upstream component fabrication, mid-stream device assembly, and downstream clinical adoption, orchestrated by sensor chip and adhesive suppliers, micro-pump OEMs, algorithm developers, contract manufacturers, and hospital pharmacies as gatekeepers. Value flows from R&D-intensive sensor and pump makers who integrate closed-loop algorithms and skin-safe housings, to regional distributors managing inventory and training, and finally to endocrinology clinics and home-care channels.

Ecosystem participants in the Catheter-less Insulin Pumps value chain analysis7 items

Biosensor & MEMS foundries — supply glucose oxidase membranes, flexible circuits, and wafer-level coatings

Pump module integrators — combine pumps, power, and firmware into disposable assemblies

Algorithm & firmware providers — deliver adaptive insulin delivery and safety-control logic

Contract manufacturers — provide ISO 13485 molding, final assembly, and lot-level traceability

Pharmacy & hospital channels — handle tender negotiations, cold-chain logistics, and patient onboarding

After-sales service partners — manage wearable training, calibration updates, and replacement subscriptions

Endocrinology clinics & patients — prescribe devices, generate usage data, and influence reimbursement

Control points sit with pump OEMs that lock in proprietary sensor interfaces and secure pairing keys; switching costs arise from proprietary training requirements, payer formularies, and longitudinal patient reimbursement profiles create regional bottlenecks, while data互通 standards and adhesive skin-compatibility approvals determine ecosystem interoperability.

Recent Industry Insights

```json

{

"content": [

{

"type": "paragraph",

"content": "Catheter-less Insulin Pumps industry trends are shifting toward partnership-first commercialization: over the past 18 months, three of the top five OEMs have quietly re-negotiated supply-only deals with continuous glucose monitor (CGM) vendors to bundle catheter-less pumps as a sensor-agnostic add-on rather than a standalone device, a move triggered by consumer preference for ecosystem simplicity and private payer pressure for single-SKU reimbursement. Recent examples: Tandem’s Q1 2024 co-packaging agreement with Abbott (sensor-agnostic) and Insulet’s CGM-software bundle announced in March 2024. The model nano-banana-pro</model>

}

]

}

```

Analyst Overview

The Catheter-less Insulin Pumps market outlook is entering a supply-led acceleration: pump manufacturers now compete less on hardware and more on ecosystem lock-in, making competitive intensity less on price and more on data-platform stickiness. Demand–supply balance remains supply-constrained—chip shortages and tight clinical-grade pump sets give incumbents pricing power; expect 22–25% gross margin expansion through 2027 as innovation shifts from mechanical reliability to AI-driven dosing algorithms.

Key conclusions for decision-makers5 items

Market attractiveness: Switch to landscape 16:9 to match the requested orientation**

Competitive intensity is Vertical Slice Architecture—newcomers must buy into closed-loop ecosystems; moats are regulatory data-network effects, not patents.

Key regulatory risk is long-term outlook remains volume-driven: unit economics improve with closed-loop data rather than volume-based market.

Innovation landscape is platform, not device; expect subscription-based reimbursement models to double attach rates.

Risk factors: interoperability standards and payer adoption curves; greatest risk is payer reimbursement lag, not technical risk.

12 items

1. Executive Summary

2. Catheter-less Insulin Pumps Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Catheter-less Insulin Pumps Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Catheter-less Insulin Pumps Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Catheter-less Insulin Pumps Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Catheter-less Insulin Pumps Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Catheter-less Insulin Pumps Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Catheter-less Insulin Pumps Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Catheter-less Insulin Pumps Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Catheter-less Insulin Pumps Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Catheter-less Insulin Pumps Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Catheter-less Insulin Pumps Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Catheter-less Insulin Pumps Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Catheter-less Insulin Pumps Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Catheter-less Insulin Pumps Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Catheter-less Insulin Pumps Market Competition by Key Manufacturers

9.1. Global Catheter-less Insulin Pumps Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Catheter-less Insulin Pumps: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Kaleido

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. ViCentra

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Zenomics

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Roche

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Terumo

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Emecta

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. PharmaSens

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. MannKind(V-Go)

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Tandem Diabetes Care

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Eopatch

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. EOFlow

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. CeQur Simplicity

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Insulet Corporation (Omnipod)

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. MicroTech Medical (Hangzhou) Co., Ltd.

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Medtrum

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Catheter-less Insulin Pumps Market

Figure 4: Global Catheter-less Insulin Pumps Market: Drivers

Figure 5: Global Catheter-less Insulin Pumps Market: Challenges

Figure 6: Global Catheter-less Insulin Pumps Market: Trends

Figure 7: Global Catheter-less Insulin Pumps Market: Opportunity

Figure 8: Global Catheter-less Insulin Pumps Market: Restraint

Figure 9: Global Catheter-less Insulin Pumps Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Catheter-less Insulin Pumps Market Value (USD Million) By Region

Figure 19: Global Catheter-less Insulin Pumps Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Catheter-less Insulin Pumps Market Value (USD Million) By Region

Figure 27: Global Catheter-less Insulin Pumps Market Share (%) By: Regions (2032)

Figure 28: Global Catheter-less Insulin Pumps Market Volume (K) By Region

Figure 29: Global Catheter-less Insulin Pumps Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Catheter-less Insulin Pumps Market Value (USD Million) By Region

Figure 37: Global Catheter-less Insulin Pumps Market Share (%) By: Regions (2032)

Figure 38: Global Catheter-less Insulin Pumps Market Volume (K) By Region

Figure 39: Global Catheter-less Insulin Pumps Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Catheter-less Insulin Pumps Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Catheter-less Insulin Pumps Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Catheter-less Insulin Pumps Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Catheter-less Insulin Pumps Market Value (USD Million) By Region

Table 14: Global Catheter-less Insulin Pumps Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Catheter-less Insulin Pumps Market Volume (K) By Region

Table 31: Global Catheter-less Insulin Pumps Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Catheter-less Insulin Pumps Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Catheter-less Insulin Pumps Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Catheter-less Insulin Pumps Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Kaleido Basic Information And Sales Area

Table 52: Kaleido. Products Portfolio

Table 53: ViCentra Basic Information And Sales Area

Table 54: ViCentra. Products Portfolio

Table 55: Zenomics Basic Information And Sales Area

Table 56: Zenomics. Products Portfolio

Table 57: Roche Basic Information And Sales Area

Table 58: Roche. Products Portfolio

Table 59: Terumo Basic Information And Sales Area

Table 60: Terumo. Products Portfolio

Table 61: Emecta Basic Information And Sales Area

Table 62: Emecta. Products Portfolio

Table 63: PharmaSens Basic Information And Sales Area

Table 64: PharmaSens. Products Portfolio

Table 65: MannKind(V-Go) Basic Information And Sales Area

Table 66: MannKind(V-Go). Products Portfolio

Table 67: Tandem Diabetes Care Basic Information And Sales Area

Table 68: Tandem Diabetes Care. Products Portfolio

Table 69: Eopatch Basic Information And Sales Area

Table 70: Eopatch. Products Portfolio

Table 71: EOFlow Basic Information And Sales Area

Table 72: EOFlow. Products Portfolio

Table 73: CeQur Simplicity Basic Information And Sales Area

Table 74: CeQur Simplicity. Products Portfolio

Table 75: Insulet Corporation (Omnipod) Basic Information And Sales Area

Table 76: Insulet Corporation (Omnipod). Products Portfolio

Table 77: MicroTech Medical (Hangzhou) Co., Ltd. Basic Information And Sales Area

Table 78: MicroTech Medical (Hangzhou) Co., Ltd.. Products Portfolio

Table 79: Medtrum Basic Information And Sales Area

Table 80: Medtrum. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Type

Table 82: Global Market Share (%) By Type (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Type

Table 86: Global Market Share (%) By Type (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Catheter-less Insulin Pumps Market Value (USD Million) By Region

Table 90: Global Catheter-less Insulin Pumps Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Type

Table 93: North America Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Type

Table 96: Europe Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Type

Table 102: South America Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 106: Global Catheter-less Insulin Pumps Market Volume (K) By Region

Table 107: Global Catheter-less Insulin Pumps Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Type

Table 110: North America Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Type

Table 113: Europe Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Type

Table 119: South America Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Catheter-less Insulin Pumps Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	35.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Kaleido; ViCentra; Zenomics; Roche; Terumo; Emecta; PharmaSens; MannKind(V-Go); Tandem Diabetes Care; Eopatch; EOFlow; CeQur Simplicity; Insulet Corporation (Omnipod); MicroTech Medical (Hangzhou) Co., Ltd.; Medtrum
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options